Lymphoma in the immunocompromised.
Lymphomas occur with a greatly increased frequency among immunocompromised individuals regardless of whether the immunodeficiency is congenital, acquired as a result of HIV infection or iatrogenic as a result of anti-rejection therapy in allograft recipients. This article focuses on the differences in clinical management of these lymphomas.
Sita-Lumsden
Ailsa
A
Department of Oncology, Chelsea and Westminster Hospital, London, UK.
Harris
Philippa
P
Bower
Mark
M
D020031:Epstein-Barr Virus Infections / Q000150:complications*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D014181:Transplantation Immunology / Q000276:immunology*